Cardura XL — Class III drug recall D-1485-2014
Terminated recall by Pfizer Inc., reported 2014-08-06, distributed nationwide. Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product
| Recall number | D-1485-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2014-06-19 |
| Classified | 2014-07-28 |
| Reported by FDA | 2014-08-06 |
| Terminated | 2015-06-03 |
| Distributed | Nationwide (US) |
| Countries outside the US | DE |
| Quantity | 22,461 bottles |
| Reason classes | specification failure |
| NDC | 00049-2710-30 |
| Lot numbers | 01/15, V130822 |
Product
Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30
Reason for recall
Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1485-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.